• Highlighting Catalent’s approach to seamless collaboration from early development through commercial supply execution
• Leveraging integrated drug delivery technologies to overcome formulation and bioavailability challenges
• Streamlining technology transfers to support predictable scale-up across dosage forms
• Driving resilient clinical and commercial supply through optimized packaging and distribution
• Enhancing operational oversight across a global CDMO network to mitigate supply risk and protect timelines